FMR CORP 13D and 13G filings for Boston Scientific Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 10:14 am Purchase |
2023-12-29 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 141,149,782 9.600% |
1,547,043 (+1.11%) |
Filing |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 139,602,739 9.529% |
34,349,164 (+32.63%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 105,253,575 7.343% |
5,174,008 (+5.17%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 100,079,567 7.017% |
34,667,924 (+53.00%) |
Filing |
| 2021-02-08 10:17 am Sale |
2021-02-05 | 13G | Boston Scientific Corporation BSX |
FMR CORP | 65,411,643 4.565% |
-62,102,864 (-48.70%) |
Filing |